Community/Retail

In a friend-of-the-court brief filed today with the U.S. Supreme Court in the case of King v. Burwell, leading groups fighting chronic disease provide scientific evidence of the grave consequences if millions of people nationwide were to lose the tax credits provided under the Affordable Care Act that provide the financial assistance they need to afford health coverage.

This first episode of a series on pharmacogenomics features an interview with Shawn Desai, PhD, JD, a chemist and member of the Georgia Bar Association.

Emphasizing the importance of promoting policies that improve patient outcomes and lead to healthier, safer communities, the National Association of Chain Drug Stores submitted a statement to the U.S. House Committee on Energy and Commerce Subcommittee on Health in lead-up to today's hearing titled "Examining Public Health Legislation to Help Patients and Local Communities."

mscripts and Avella Specialty Pharmacy have recently completed analyzing data demonstrating the effectiveness of mobile pharmacy apps in helping HIV patients better manage their disease through improved medication adherence. Results from this analysis show that HIV patients using a mobile app which provides refill reminders, dosage reminders and other prescription management functionality are 2.9 times more likely to be adherent.

The American Pharmacists Association Academy of Pharmacy Practice and Management and Academy of Pharmaceutical Research and Science announced the following election slate for the 2015 APhA Elections:

The American Pharmacists Association today announced the slate of candidates for its Board of Trustees, President-elect and Honorary President. The elections for these positions will be held March 27-May 25, 2015. Association members will have the opportunity to meet the candidates at the APhA Annual Meeting and Exposition in San Diego, March 27-30, 2015.

"The Generic Pharmaceutical Association (GPhA) is deeply disappointed in today's 21st Century Cures discussion draft. While we appreciate that it is a draft, in its current form, the bill would upset the important balance between creating competition and encouraging innovation in the pharmaceutical marketplace, putting savings at risk and limiting access to affordable medicines for millions of American patients.

New research in the American Heart Association's journal Circulation shows that long-term exposure to elevated cholesterol substantially increases lifetime risk for heart disease. For every ten years you have even mildly elevated cholesterol between the ages of 35 and 55, your risk of heart disease may be increased by nearly 40 percent.

The FDA today approved Ivax Pharmaceuticals' esomeprazole magnesium delayed-release capsules, the first generic version of AstraZeneca's proton pump inhibitor Nexium, for the treatment of gastroesophageal reflux disease in patients aged >1 year.

Time Is on Your Side

By

Starting the New Year can be both exciting and depressing. It's easy to feel like a failure on January 2 after falling short on a resolution you had set for yourself just 24 hours prior.